Inventor · disambiguated record
Ronnie Hanecak
Also filed as: BENNETT C FRANK · HANECAK RONNIE · HANECAK RONNIE C
14 granted patents·6 pending applications·899 citations·filing 1992–2010
95Inventor score
Files withISIS PHARMACEUTICALS INC12PHENEX PHARMACEUTICALS AG2BAUER ULRIKE1BENNETT C F1HANECAK RONNIE C1
Top patents by PatentIndex Score
20 records- 0195US7067497B2Modulation of telomere length by oligonucleotides having a G-core sequenceISIS PHARMACEUTICALS INC·Filed 2002·Granted Jun 27, 2006·57 cites·16 claims
- 0295US6174868B1Compositions and methods for treatment of hepatitis C virus-associated diseasesISIS PHARMACEUTICALS INC·Filed 1997·Granted Jan 16, 2001·141 cites·11 claims
- 0392US5952490AOligonucleotides having a conserved G4 core sequenceISIS PHARMACEUTICALS INC·Filed 1993·Granted Sep 14, 1999·69 cites·27 claims
- 0490US6608191B1Compositions and methods for treatment of hepatitis C virus-associated diseasesISIS PHARMACEUTICALS INC·Filed 2000·Granted Aug 19, 2003·34 cites·4 claims
- 0590US6423489B1Compositions and methods for treatment of Hepatitis C virus-associated diseasesISIS PHARMACEUTICALS INC·Filed 1995·Granted Jul 23, 2002·120 cites·7 claims
- 0690US5514577AOligonucleotide therapies for modulating the effects of herpes virusesISIS PHARMACEUTICALS INC·Filed 1993·Granted May 7, 1996·153 cites·2 claims
- 0787US7098336B2FXR NR1H4 nuclear receptor binding compoundsPHENEX PHARMACEUTICALS AG·Filed 2002·Granted Aug 29, 2006·18 cites·13 claims
- 0887US6974830B2NR1H4 nuclear receptor binding compoundsPHENIX PHARMACEUTICALS AG·Filed 2002·Granted Dec 13, 2005·32 cites·19 claims
- 0987US6284458B1Compositions and methods for treatment of hepatitis C virus-associated diseasesISIS PHARMACEUTICALS INC·Filed 1993·Granted Sep 4, 2001·87 cites·6 claims
- 1086US6995146B2Compositions and methods for treatment of hepatitis C virus-associated diseasesISIS PHARMACEUTICALS INC·Filed 2001·Granted Feb 7, 2006·26 cites·8 claims
- 1183US6391542B1Compositions and methods for treatment of Hepatitis C virus-associated diseasesISIS PHARMACEUTICALS INC·Filed 1996·Granted May 21, 2002·95 cites·8 claims
- 1282US7034046B2NR1H4 nuclear receptor binding compoundsPHENEX PHARMACEUTICALS AG·Filed 2002·Granted Apr 25, 2006·19 cites·7 claims
- 1372US5698391AMethods for synthetic unrandomization of oligomer fragmentsISIS PHARMACEUTICALS INC·Filed 1994·Granted Dec 16, 1997·36 cites·80 claims
- 1459US2007015723A1Antiviral oligonucleotides having a conserved G4 core sequenceISIS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1555US2005261228A1Antisense modulation of interleukin 12 P35 subunit expressionBENNETT C F·Filed 2005·Application pending·0 cites
- 1653US2011124715A1Antiviral Oligonucleotides Having a Conserved G4 Core SequenceHANECAK RONNIE C·Filed 2010·Application pending·0 cites
- 1753US2004033978A1Compositions and methods for treatment of Hepatitis C virus-associated diseasesFiled 2003·Application pending·0 cites
- 1848US2004049021A1Compositions and mehtods for treatment of Hepatitis C virus-associated diseasesFiled 2003·Application pending·0 cites
- 1946US5672472ASynthetic unrandomization of oligomer fragmentsISIS PHARMACEUTICALS INC·Filed 1992·Granted Sep 30, 1997·12 cites·64 claims
- 2037US2007010562A1Nr1h4 nuclear receptor binding compoundsBAUER ULRIKE·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ronnie Hanecak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →